Evidence map›Paper›PMID 32975842›Full record

ArticleJournal of medical virology2021

COVID-19 in people living with HIV: Clinical implications of dynamics of the immune response to SARS-CoV-2.

Annalisa Mondi, Eleonora Cimini, Francesca Colavita, Stefania Cicalini, Carmela Pinnetti, Giulia Matusali, Rita Casetti, Markus Maeurer, Alessandra Vergori, Valentina Mazzotta and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical virology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 3 pooled it
1.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 3 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2021
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 2 institutions in 3 countries.

Annalisa MondiHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.ORCID 0000-0003-4096-2610
Eleonora CiminiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Francesca ColavitaLaboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Stefania CicaliniHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Carmela PinnettiHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Giulia MatusaliLaboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Rita CasettiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Markus MaeurerImmunotherapy Programme, Champalimaud Centre for the Unknown, Lisbon, Portugal.
Alessandra VergoriHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.ORCID 0000-0001-6944-0686
Valentina MazzottaHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Roberta GagliardiniHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Federico De ZottisHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Vincenzo SchininàRadiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
Enrico GirardiClinical Epidemiology Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Vincenzo PuroAIDS Reference Centre-National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy.
Giuseppe IppolitoScientific Direction, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Francesco VaiaHealth Direction, National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, Rome, Italy.
Maria Rosaria CapobianchiLaboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.ORCID 0000-0003-3465-0071
Concetta CastillettiLaboratory of Virology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Chiara AgratiLaboratory of Cellular Immunology and Pharmacology, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Andrea AntinoriHIV/AIDS Unit, National Institute for Infectious Diseases, Lazzaro Spallanzani IRCCS, Rome, Italy.
Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITChampalimaud Foundation · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little evidence on coronavirus disease 2019 (COVID-19) in people living with HIV (PLWH) is currently available. We reported clinical and viroimmunological data of all HIV-positive patients admitted to our center with COVID-19 from March 1 to May 12, 2020. Overall, five patients were included: all were virologically-suppressed on antiretroviral therapy and CD4+ count was greater than 350 cell/mm

Indexed as

COVID-19 Drug TreatmentAntibodies, NeutralizingAntibodies, ViralAnti-Retroviral AgentsCD4 Lymphocyte CountCoinfectionCytokinesDolutegravirFemaleHeterocyclic Compounds, 3-RingHIV InfectionsHIV Integrase InhibitorsHumansImmunity, HumoralMaleMiddle AgedAntibodies, NeutralizingAntibodies, ViralAnti-Retroviral AgentsCytokinesDolutegravirHeterocyclic Compounds, 3-RingHIV Integrase InhibitorsOxazinesPiperazinesPyridonesReverse Transcriptase InhibitorsRNA, ViralTenofovirCOVID-19HIV infectionimmune responseSARS-CoV-2

Identifiers

PMID32975842
PMCPMC7537181
OpenAlexW3088586151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.